214 related articles for article (PubMed ID: 37717649)
1. Vaccination after developing long COVID: Impact on clinical presentation, viral persistence, and immune responses.
Nayyerabadi M; Fourcade L; Joshi SA; Chandrasekaran P; Chakravarti A; Massé C; Paul ML; Houle J; Boubekeur AM; DuSablon C; Boudreau V; Bovan D; Darbinian E; Coleman EA; Vinci S; Routy JP; Hétu PO; Poudrier J; Falcone EL
Int J Infect Dis; 2023 Nov; 136():136-145. PubMed ID: 37717649
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition.
Limoges MA; Quenum AJI; Chowdhury MMH; Rexhepi F; Namvarpour M; Akbari SA; Rioux-Perreault C; Nandi M; Lucier JF; Lemaire-Paquette S; Premkumar L; Durocher Y; Cantin A; Lévesque S; Dionne IJ; Menendez A; Ilangumaran S; Allard-Chamard H; Piché A; Ramanathan S
Front Immunol; 2023; 14():1223936. PubMed ID: 37809081
[TBL] [Abstract][Full Text] [Related]
3. Early antibody treatment, inflammation, and risk of post-COVID conditions.
Gebo KA; Heath SL; Fukuta Y; Zhu X; Baksh S; Abraham AG; Habtehyimer F; Shade D; Ruff J; Ram M; Laeyendecker O; Fernandez RE; Patel EU; Baker OR; Shoham S; Cachay ER; Currier JS; Gerber JM; Meisenberg B; Forthal DN; Hammitt LL; Huaman MA; Levine A; Mosnaim GS; Patel B; Paxton JH; Raval JS; Sutcliffe CG; Anjan S; Gniadek T; Kassaye S; Blair JE; Lane K; McBee NA; Gawad AL; Das P; Klein SL; Pekosz A; Bloch EM; Hanley D; Casadevall A; Tobian AAR; Sullivan DJ;
mBio; 2023 Oct; 14(5):e0061823. PubMed ID: 37724870
[TBL] [Abstract][Full Text] [Related]
4. Serological response to vaccination in post-acute sequelae of COVID.
Joung S; Weber B; Wu M; Liu Y; Tang AB; Driver M; Sternbach S; Wynter T; Hoang A; Barajas D; Kao YH; Khuu B; Bravo M; Masoom H; Tran T; Sun N; Botting PG; Claggett BL; Prostko JC; Frias EC; Stewart JL; Robertson J; Kwan AC; Torossian M; Pedraza I; Sterling C; Goldzweig C; Oft J; Zabner R; Fert-Bober J; Ebinger JE; Sobhani K; Cheng S; Le CN
BMC Infect Dis; 2023 Feb; 23(1):97. PubMed ID: 36797666
[TBL] [Abstract][Full Text] [Related]
5. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
Xie Y; Choi T; Al-Aly Z
JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
[TBL] [Abstract][Full Text] [Related]
6. Potential reduction of post-acute sequelae of SARS-CoV-2 symptoms via vaccination.
Vanichkachorn G; Gilman E; Ganesh R; Mueller M; Swift M; Breeher L; Murad MH
J Investig Med; 2023 Dec; 71(8):889-895. PubMed ID: 37497990
[TBL] [Abstract][Full Text] [Related]
7. Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients.
Peghin M; De Martino M; Palese A; Gerussi V; Bontempo G; Graziano E; Visintini E; D'Elia D; Dellai F; Marrella F; Fabris M; Curcio F; Sartor A; Isola M; Tascini C
Clin Microbiol Infect; 2022 Aug; 28(8):1140-1148. PubMed ID: 35339673
[TBL] [Abstract][Full Text] [Related]
8. Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population.
Tannous J; Pan AP; Potter T; Bako AT; Dlouhy K; Drews A; Sostman HD; Vahidy FS
BMJ Open; 2023 Apr; 13(4):e067611. PubMed ID: 37019490
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition.
Fischer C; Willscher E; Paschold L; Gottschick C; Klee B; Diexer S; Bosurgi L; Dutzmann J; Sedding D; Frese T; Girndt M; Hoell JI; Gekle M; Addo MM; Schulze Zur Wiesch J; Mikolajczyk R; Binder M; Schultheiß C
NPJ Vaccines; 2024 Feb; 9(1):23. PubMed ID: 38316833
[TBL] [Abstract][Full Text] [Related]
10. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
Front Immunol; 2021; 12():746021. PubMed ID: 35082777
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study.
Zhu X; Gebo KA; Abraham AG; Habtehyimer F; Patel EU; Laeyendecker O; Gniadek TJ; Fernandez RE; Baker OR; Ram M; Cachay ER; Currier JS; Fukuta Y; Gerber JM; Heath SL; Meisenberg B; Huaman MA; Levine AC; Shenoy A; Anjan S; Blair JE; Cruser D; Forthal DN; Hammitt LL; Kassaye S; Mosnaim GS; Patel B; Paxton JH; Raval JS; Sutcliffe CG; Abinante M; Broderick P; Cluzet V; Cordisco ME; Greenblatt B; Petrini J; Rausch W; Shade D; Lane K; Gawad AL; Klein SL; Pekosz A; Shoham S; Casadevall A; Bloch EM; Hanley D; Sullivan DJ; Tobian AAR
Lancet Microbe; 2023 Sep; 4(9):e692-e703. PubMed ID: 37659419
[TBL] [Abstract][Full Text] [Related]
12. Viral persistence, reactivation, and mechanisms of long COVID.
Chen B; Julg B; Mohandas S; Bradfute SB;
Elife; 2023 May; 12():. PubMed ID: 37140960
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery.
Kumar NP; Venkataraman A; Nancy A; Moideen K; Varadarjan P; Selladurai E; Sangaralingam T; Selvam R; Thimmaiah A; Natarajan S; Ramasamy G; Hissar S; Radayam Ranganathan U; Babu S
J Infect Dis; 2022 Sep; 226(7):1215-1223. PubMed ID: 35932220
[TBL] [Abstract][Full Text] [Related]
14. Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study.
Bellan M; Apostolo D; Albè A; Crevola M; Errica N; Ratano G; Tonello S; Minisini R; D'Onghia D; Baricich A; Patrucco F; Zeppegno P; Gramaglia C; Balbo PE; Cappellano G; Casella S; Chiocchetti A; Clivati E; Giordano M; Manfredi M; Patti G; Pinato DJ; Puricelli C; Raineri D; Rolla R; Sainaghi PP; Pirisi M;
Front Immunol; 2022; 13():1038227. PubMed ID: 36601115
[TBL] [Abstract][Full Text] [Related]
15. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
[TBL] [Abstract][Full Text] [Related]
16. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
17. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
18. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study.
Wynberg E; Han AX; Boyd A; van Willigen HDG; Verveen A; Lebbink R; van der Straten K; Kootstra N; van Gils MJ; Russell C; Leenstra T; de Jong MD; de Bree GJ; Prins M;
Vaccine; 2022 Jul; 40(32):4424-4431. PubMed ID: 35725782
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection.
Jacobs LMC; Wintjens MSJN; Nagy M; Willems L; Ten Cate H; Spronk HMH; van Kuijk SMJ; Ghossein-Doha C; Netea MG; Groh LA; van Petersen AS; Warlé MC
Front Immunol; 2023; 14():1182182. PubMed ID: 37868959
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients.
Normandin E; Holroyd KB; Collens SI; Shaw BM; Siddle KJ; Adams G; Rudy M; Solomon IH; Anahtar MN; Lemieux JE; Trombetta BA; Kivisakk P; Arnold SE; Rapalino O; Piantadosi AL; Sen P; Rosenberg ES; Branda J; Sabeti PC; Mukerji SS
J Neurol Sci; 2021 Nov; 430():120023. PubMed ID: 34678659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
